BioCentury | Feb 22, 2018
Politics & Policy

NZ government to continue funding for rare diseases

The New Zealand Parliament Associate Minister of Health Julie Anne Genter said that PHARMAC, the government agency which determines public funding for pharmaceuticals, will continue trial-specific funds for rare diseases this year and the NZ$5...
BioCentury | May 2, 2005
Finance

MPM's portfolio

...4/3/03 $22.6 Michael Steinmetz Eyetech (EYET) Ophthalmic; Drug delivery U.S. Series C 8/7/01 $108.5 None Genteric...
BioCentury | Dec 20, 2004
Finance

Ebb & Flow

...Huffman was named CFO and principal at Sanderling Ventures. Huffman, who was previously CFO at Genteric...
BioCentury | Dec 15, 2004
Financial News

Sanderling names Huffman CFO

...COO of the family investment office for an individual investor. Previously, Huffman was CFO of Genteric...
BioCentury | Jun 9, 2003
Company News

Genteric management update

Genteric Inc. , Alameda, Calif. Business: Gene/Cell therapy Promoted: Mitchell Finer to president and CEO from CSO; he replaces Roland Scollay, who resigned WIR Staff...
BioCentury | Jun 5, 2003
Company News

Genteric promotes Finer to CEO

...Gene therapy company Genteric (Alameda, Calif.) promoted Mitchell Finer to president and CEO from CSO. He...
BioCentury | May 26, 2003
Company News

Genetronics, Genteric deal

...electroporation in delivering DNA to the salivary gland. The deal combines GEB's electroporation technology with Genteric's...
...will jointly own data from the collaboration. Genetronics Biomedical Corp. (TSE:GEB; GEB), San Diego, Calif. Genteric Inc....
BioCentury | Mar 10, 2003
Company News

Juvaris management update

...Hired: Martin Cleary as chairman, president and CEO, formerly president, CEO and a director at Genteric Inc. WIR...
BioCentury | Feb 3, 2003
Company News

Genteric management update

Genteric Inc. , Alameda, Calif. Business: Gene/Cell therapy Hired: Mitchell Finer as CSO, formerly VP of R&D at Aventis S.A. 's Gencell S.A. subsidiary WIR Staff...
BioCentury | Sep 30, 2002
Company News

Genteric management update

Genteric Inc. , Alameda, Calif. Business: Gene/Cell therapy Promoted: Roland Scollay to president and CEO from VP of research and CSO; he replaces Martin Cleary, who resigned WIR Staff...
Items per page:
1 - 10 of 31
BioCentury | Feb 22, 2018
Politics & Policy

NZ government to continue funding for rare diseases

The New Zealand Parliament Associate Minister of Health Julie Anne Genter said that PHARMAC, the government agency which determines public funding for pharmaceuticals, will continue trial-specific funds for rare diseases this year and the NZ$5...
BioCentury | May 2, 2005
Finance

MPM's portfolio

...4/3/03 $22.6 Michael Steinmetz Eyetech (EYET) Ophthalmic; Drug delivery U.S. Series C 8/7/01 $108.5 None Genteric...
BioCentury | Dec 20, 2004
Finance

Ebb & Flow

...Huffman was named CFO and principal at Sanderling Ventures. Huffman, who was previously CFO at Genteric...
BioCentury | Dec 15, 2004
Financial News

Sanderling names Huffman CFO

...COO of the family investment office for an individual investor. Previously, Huffman was CFO of Genteric...
BioCentury | Jun 9, 2003
Company News

Genteric management update

Genteric Inc. , Alameda, Calif. Business: Gene/Cell therapy Promoted: Mitchell Finer to president and CEO from CSO; he replaces Roland Scollay, who resigned WIR Staff...
BioCentury | Jun 5, 2003
Company News

Genteric promotes Finer to CEO

...Gene therapy company Genteric (Alameda, Calif.) promoted Mitchell Finer to president and CEO from CSO. He...
BioCentury | May 26, 2003
Company News

Genetronics, Genteric deal

...electroporation in delivering DNA to the salivary gland. The deal combines GEB's electroporation technology with Genteric's...
...will jointly own data from the collaboration. Genetronics Biomedical Corp. (TSE:GEB; GEB), San Diego, Calif. Genteric Inc....
BioCentury | Mar 10, 2003
Company News

Juvaris management update

...Hired: Martin Cleary as chairman, president and CEO, formerly president, CEO and a director at Genteric Inc. WIR...
BioCentury | Feb 3, 2003
Company News

Genteric management update

Genteric Inc. , Alameda, Calif. Business: Gene/Cell therapy Hired: Mitchell Finer as CSO, formerly VP of R&D at Aventis S.A. 's Gencell S.A. subsidiary WIR Staff...
BioCentury | Sep 30, 2002
Company News

Genteric management update

Genteric Inc. , Alameda, Calif. Business: Gene/Cell therapy Promoted: Roland Scollay to president and CEO from VP of research and CSO; he replaces Martin Cleary, who resigned WIR Staff...
Items per page:
1 - 10 of 31